Proteome Sciences plc

Equities

PRM

GB0003104196

Medical Equipment, Supplies & Distribution

Delayed London S.E. Other stock markets 04:38:15 2024-04-26 am EDT			5-day change	1st Jan Change
4.59 ^GBX	+30.77%		+39.09%	+1.32%

11:42am	AIM WINNERS & LOSERS: Proteome Sciences rises on GBP500,000 contract	AN
10:16am	Thoma Bravo snaps up Darktrace for USD5 billion	AN

Proteome Sciences reaches "sales milestone" from contract

January 05, 2023 at 05:46 am EST

Proteome Sciences PLC - drug development services provider - Achieves "cumulative sales milestone" with life sciences company Thermo Fisher Scientific Inc. Says a payment of GBP870,000 has been received by the company and will be recognised in the 2022 financial year. Proteome Sciences has an exclusive licence and distributor agreement with Thermo Scientific.

Current stock price: 3.50 pence

12-month change: down 33%

By Sophie Rose; Alliance News reporter

Comments and questions to newsroom@alliancenews.com

Stocks mentioned in the article

	Add to a list Add to a list 0 selected To use this feature you must be a member Log in Sign up	Price	Change	5d. change	Capi.
	THERMO FISHER SCIENTIFIC	571.7 USD	-0.98%	+5.58%	218B
	PROTEOME SCIENCES PLC	4.59 GBX	+30.77%	+39.09%	12.95M

Latest news about Proteome Sciences plc

AIM WINNERS & LOSERS: Proteome Sciences rises on GBP500,000 contract	05:42am	AN
Thoma Bravo snaps up Darktrace for USD5 billion	04:16am	AN
Proteome Sciences shares drop as revenue plunges and swings to loss	Apr. 10	AN
Proteome Sciences plc Reports Earnings Results for the Full Year Ended December 31, 2023	Apr. 10	CI
Proteome Sciences Completes New US Lab Setup	Jan. 02	MT
Proteome Sciences Announces the Completion of Installation and Setup of Equipment in Its New US Laboratory in San Diego, California	Jan. 02	CI
Proteome Sciences says San Diego lab now fully operational	Jan. 02	AN
AIM WINNERS & LOSERS: Totally slides again; Proteome warns on earnings	Nov. 30	AN
Proteome Sciences shares drop as cuts annual revenue outlook	Nov. 30	AN
Proteome Sciences sees shares surge on SysQuant service launch	23-10-02	AN
Proteome Sciences plc Announces the Launch of Sysquant® SCP, the Commercial Service for Single Cell Proteomics Using the Power of its TMTpro? Isobaric Labelling Reagents	23-10-02	CI
FTSE 100 Finishes Flat After Choppy Week	23-08-25	DJ
UK 2063 Gilt Seen Attractively Valued Ahead of Syndicated Tap	23-08-25	DJ
FTSE 100 pushes higher ahead of Fed chair speech	23-08-25	AN
AIM WINNERS & LOSERS: Panthera Resources secures litigation financing	23-08-25	AN
Proteome Sciences shares fall as swings to interim loss on costs	23-08-25	AN
Earnings Flash (PRM.L) PROTEOME SCIENCES Posts H1 Loss GBX-0.20	23-08-25	MT
Proteome Sciences plc Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-25	CI
OnTheMarket new CFO Tom Carter starts role	23-07-04	AN
Proteome Sciences repays GBP824,400 loan in full to Vulpes	23-06-01	AN
Brand Architekts CFO to Step Down in June; Successor Named	23-05-26	MT
FTSE 100 Closes Down 0.35% After Corporate Updates; Melrose Industries Shines on Guidance Lift	23-05-17	DJ
Proteome Sciences revenue up; Mpac sees improved 2023	23-05-17	AN
Proteome Sciences expanding to US with San Diego facility	23-05-12	AN
Proteome Sciences to Set Up Facility in California, US; Shares Rise 13%	23-05-12	MT

Chart Proteome Sciences plc

Duration

Period

More charts

Company Profile

Proteome Sciences plc is a specialist provider of contract proteomics services. The services enable drug discovery, development, and biomarker identification and employ workflows for the optimum analysis of tissues, cells, and body fluids. Its principal activities involve protein biomarker research and development. It uses high-sensitivity techniques to detect and characterize differentially expressed proteins in biological samples for diagnostic, prognostic, and therapeutic applications. SysQuant and TMT MS2 are its unbiased methods for identifying and contextualizing new targets and defining mechanisms of biological activity, while analysis using super-depletion and TMTcalibrator provides access to over 8,500 circulating plasma proteins for the discovery of disease-related biomarkers. In addition, it has invented and developed the technology for TMT and TMTpro, and manufactures these small, protein-reactive chemical reagents, which are sold for multiplex quantitative proteomics.

Sector

Medical Equipment, Supplies & Distribution

Calendar

2024-07-24 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Other Medical Equipment, Supplies & Distribution

	1st Jan change	Capi.
PROTEOME SCIENCES PLC	+1.32%	12.95M
ABBOTT LABORATORIES	-2.92%	185B
MEDTRONIC PLC	-3.80%	105B
BECTON, DICKINSON AND COMPANY	-5.48%	66.59B
DEXCOM, INC.	+11.22%	54.66B
CENCORA, INC.	+16.74%	47.78B
HOYA CORPORATION	+4.06%	41.26B
WEST PHARMACEUTICAL SERVICES, INC.	+4.56%	26.95B
METTLER-TOLEDO INTERNATIONAL, INC.	+1.64%	26.37B
TERUMO CORPORATION	+12.96%	24.8B

Other Medical Equipment, Supplies & Distribution